Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epidemiology
99%
Celiac Disease
94%
Odds Ratio
82%
Population-based Study
68%
Chronic Pancreatitis
63%
Population-based
63%
Inflammatory Bowel Disease
63%
95% Confidence Interval
55%
All-cause Mortality
45%
Gastroparesis
40%
Acute Pancreatitis
37%
Confidence Interval
31%
Maternal Outcomes
31%
Obstetrical Outcomes
31%
Increasing Prevalence
31%
Depression Disorder
31%
Depression Prevalence
31%
Barrett's Esophagus
31%
Anxiety Prevalence
31%
Anxiety Disorders
31%
Pyloroplasty
31%
Neuroendocrine Tumor
31%
Unites States
31%
Gallbladder Cancer
31%
Racial Disparities
31%
Disease Outcome
31%
Non-associated
31%
Oral Small Molecules
31%
Major Adverse Cardiovascular Events
31%
Venous Thromboembolism
31%
Psychiatric Disorders
31%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
31%
Gastrointestinal Side Effects
31%
Receptor Agonist
31%
Type 2 Diabetes Mellitus (T2DM)
31%
Glucagon-like
31%
Black Women
31%
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
31%
Disease Severity
31%
Social Determinants of Health (SDoH)
31%
Neonatal Outcomes
31%
1 Receptor
31%
Infection Rate
31%
Meta-analysis
31%
United States
28%
Explorys
27%
Large Database
20%
Ulcerative Colitis
19%
Crohn's Disease
19%
Metabolic Dysfunction-associated Steatohepatitis
17%
Medicine and Dentistry
Cohort Effect
100%
Coeliac Disease
94%
Odds Ratio
73%
Chronic Pancreatitis
63%
Inflammatory Bowel Disease
63%
Prevalence
52%
Diseases
35%
Stomach Paresis
31%
Acute Pancreatitis
31%
Barrett Esophagus
31%
Diagnosis of Chronic Pancreatitis
31%
Gallbladder Cancer
31%
Neuroendocrine Tumor
31%
Pyloroplasty
31%
Neurodevelopmental Disorder
31%
Biological Product
31%
Venous Thromboembolism
31%
Racial Disparity
31%
Cardiovascular Disease
31%
Oral
31%
All Cause Mortality
15%
Myocardial Infarction
15%
Apoplexy
15%
Ulcerative Colitis
13%
Crohn's Disease
13%
Advanced Therapy
13%
Patient with Inflammatory Bowel Disease
12%
Patient with Ulcerative Colitis
9%
Patient with Crohn's Disease
9%
Vedolizumab
9%
Tofacitinib
9%
Corticosteroid
9%
Ustekinumab
9%
Adalimumab
9%
Stomach Emptying
8%
Pregnant Woman
8%
Propensity Score Matching
7%
Neoplasm
7%
Multivariate Analysis
6%
Electronic Health Record
6%
Patient Referral
6%
Psychiatry
6%
Eating Disorder
6%
Pervasive Developmental Disorder
6%
Attention Deficit Disorder
6%
Abdominal Pain
6%
Clinician
6%
Gastroesophageal Reflux
5%
Pre-Eclampsia
5%
Logistic Regression Analysis
5%